Biochemical and Biophysical Research Communications
Rock2 stabilizes β-catenin to promote tumor invasion and metastasis in colorectal cancer
Introduction
Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer-related death worldwide. Although surgical resection is regarded as the standard curative treatment for CRC, the metastasis and recurrence rates after radical resection of CRC remain high [1]. Thus, it is important to investigate the molecular mechanisms involved in CRC progression and metastasis.
Rho-associated coiled-coil forming protein kinase 2 (Rock2) belongs to a family of serine/threonine kinases that regulate important cellular processes, such as cell morphology, shape, adhesion and migration [2], [3], [4]. Recently, emerging evidence has linked the biological function of Rock2 to tumor metastasis. For example, increased Rock2 expression has been reported in several types of cancers, including hepatocellular carcinoma (HCC), human laryngeal squamous cell carcinoma and lung cancer, and this overexpression is associated with metastasis and shorter survival of cancer patients [5], [6], [7]. However, the expression of Rock2 in CRC and its specific mechanism of action in the process of CRC invasion and metastasis remain unclear.
The protein β-catenin, a key mediator of the β-catenin/TCF4 signaling pathway [8], plays an important role in CRC carcinogenesis and tumor metastasis [9], [10]. It is well known that β-catenin is targeted to ubiquitin-proteasome-mediated degradation [11]. In addition, we previously demonstrated that Rock2 can modify the ubiquitin degradation of MMP2 and CDC25A [12], [13]. Thus, we presumed that Rock2 might also regulate β-catenin by affecting β-catenin ubiquitination degradation.
In this study, we first demonstrated that Rock2 is upregulated in CRC tissues compared with non-tumor tissues and that the overexpression of Rock2 is associated with metastasis and poor survival of CRC patients. In addition, we also provided the first evidence that Rock2 promotes the migration and invasion of CRC cells via the β-catenin/TCF4 pathway. Further investigations indicated that Rock2 can stabilize β-catenin expression by modulating the ubiquitination and degradation of β-catenin.
Section snippets
Samples
Human CRC specimens were collected from 116 patients who underwent CRC resection at the Second Affiliated Hospital of Nanchang University between January 2008 and December 2013. The clinicopathologic characteristics of CRC patients are described in Supplemental Table S1. Informed consent was obtained from each patient, and the study protocol was approved by the Ethics Committee of the Second Affiliated Hospital of Nanchang University.
Cell culture, plasmids and reagents
The human CRC cell lines SW480, SW620, LOVO, DLD-1 and
Rock2 expression is associated with the progression and outcome of CRC
To explore the expression and significance of Rock2 in CRC tissues, we first examined Rock2 expression in 116 CRC tissue samples and the corresponding adjacent tissues by qRT-PCR, immunohistochemistry (IHC) and western blotting. The qRT-PCR experiments revealed that the average fold change of Rock2 mRNA expression in tumor tissues was significantly higher than in paired nontumor tissues (Fig. 1A). The IHC results showed that the Rock2 protein was highly expressed in 62.07% (72/116) of the CRC
Discussion
Rock2 is among the immediate downstream effectors of Rho, which play important roles in many physiological functions, including neurite growth retardation, postnatal development, and smooth muscle contractions [4]. In recent years, studies have shown that Rock2 is highly expressed in a variety of malignant tumors, where it plays an important role in tumor invasion and metastasis. For example, the upregulated expression of Rock2 could promote HCC invasion and metastasis [5]. Additionally, in
Acknowledgments
We thank Elsevier's English Language Editing service for editing the manuscript. This study was supported by grants from the National Natural Science Foundation of China (no. 81360325), the Project of Jiangxi Provincial Department of Science and Technology (nos.20132BDH80031 and 20142BAB215037) and the Project of Jiangxi Provincial Department of Education (no.KJLD12053).
References (21)
- et al.
Beta-catenin: a key mediator of Wnt signaling
Curr. Opin. Genet. Dev.
(1998) - et al.
Rock2 promotes the invasion and metastasis of hepatocellular carcinoma by modifying MMP2 ubiquitination and degradation
Biochem. Biophysical Res. Commun.
(2014) - et al.
Rock2 regulates Cdc25A through ubiquitin proteasome system in hepatocellular carcinoma cells
Exp. Cell Res.
(2012) - et al.
Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma
J. Biol. Chem.
(2009) - et al.
ROCK2 promotes HCC proliferation by CEBPD inhibition through phospho-GSK3beta/beta-catenin signaling
FEBS Lett.
(2015) - et al.
ROCK2 regulates bFGF-induced proliferation of SH-SY5Y cells through GSK-3beta and beta-catenin pathway
Brain Res.
(2013) Wnt/beta-catenin signaling in development and disease
Cell
(2006)- et al.
Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/beta-catenin signaling pathway
Cancer Lett.
(2015) - et al.
Genetics, diagnosis and management of colorectal cancer (Review)
Oncol. Rep.
(2015) - et al.
ROCK1 and ROCK2 regulate epithelial polarisation and geometric cell shape
Biol. Cell/Under Auspices Eur. Cell Biol. Organ.
(2012)
Cited by (21)
Should we keep rocking? Portraits from targeting Rho kinases in cancer
2020, Pharmacological ResearchCitation Excerpt :Increased ROCK2 expression was also found in gastrointestinal tumors compared to adjacent non-cancer tissues, being not only correlated with tumor grade, infiltration depth, lymph node invasion and Ki-67 index, but also, projected poor prognosis [70,76,77]. Particularly, overexpression of ROCK2 in colon cancer is a critical mediator of invasion through its modulation of matrix metalloproteinase 2 (MMP-2) and -13 (MMP-13) at the sites of invadopodia [78], being directly correlated with tumor metastasis and poor prognosis in this tumor [79]. A more recent study in oral squamous cell carcinomas revealed advanced clinical stage and increased density of cancer-associated fibroblasts in samples with high ROCK2 expression, suggesting that this kinase might be important for tumor progression [80].
ROCK2 promotes osteosarcoma growth and metastasis by modifying PFKFB3 ubiquitination and degradation
2019, Experimental Cell ResearchCitation Excerpt :Finally, expression of the corresponding protein was observed via chemiluminescence. qRT-PCR assays were performed as previously described [24,25]. Primer sequences were as follows: ROCK2 (forward: 5′-GGTATCTGTACATGGTAATGG-3′; reverse: 5′-GGAGTGTATTGCATCCAGAG-3′), PFKFB3 (forward: 5′-GATGCCCTTCAGGAAAGCCT-3′; reverse: 5′-TTGAACACTTTTGTGGGGACGC-3′), and GAPDH (forward: 5′-CCTGCCGGTGACTAACCCTG-3′; reverse: 5′-AGTTAAAAGCAGCCCTGGTG-3′).
Rock2 promotes RCC proliferation by decreasing SCARA5 expression through β-catenin/TCF4 signaling
2016, Biochemical and Biophysical Research CommunicationsCitation Excerpt :Our previous work as well as other studies provided evidence that Rock2 is frequently overexpressed in hepatocellular carcinoma (HCC), colorectal cancer (CRC), melanoma and so on [10–13]. Additionally, Rock2 overexpression is associated with cancer progression and poor prognosis [11,14]. However, the expression of Rock2 in RCC and the specific mechanism of its effect on RCC proliferation remain unclear.
- 1
These authors contributed equally to this work.